This webpage provides information on early HIV-related mouth sores, including pictures to help with identification. It discusses common oral symptoms associated with early HIV infection, such as ulcers, thrush, and other lesions, and highlights their significance in early diagnosis.
This article discusses how the U.S. Preventive Services Task Force has proposed new draft guidelines for cervical cancer screening, allowing women aged 30 and older to self-collect HPV samples. This approach aims to improve access to screening, particularly for Black and Hispanic women. The guidelines recommend HPV testing every five years for women aged 30 to 65, alongside traditional Pap tests, and the self-collection method is expected to increase screening rates by offering a more comfortable option.
In this podcast episode, Anna Person, MD, FIDSA discusses opportunities to work with Medicaid managed care plans to optimize HIV care with Jenny Babcock, Senior Vice President for Medicaid Policy and Director of Strategic Operations at Association for Community Affiliated Plans and, Doug Wirth, President and CEO of Amida Care.
This fact sheet about the third episode of the "Let's Talk HIV" podcast explores Medicaid managed care plans' role in accessing HIV care. It encourages healthcare providers to understand their state's coverage options, engage with these plans to enhance care, and advocate for innovative funding from Medicaid agencies. The episode also highlights the need to address social determinants of health to improve outcomes for people living with HIV.
This webpage offers information on syphilis and its causes, symptoms, and treatment options.
This video highlights the rules about who to screen and vaccinate for hepatitis B and how they are now more clinician-friendly.
In this episode of Beyond Substance podcast, Jason Rush shares his journey through addiction and hepatitis C, while Dr. Janet Arno provides expert insight on treatment and public health solutions.
This journal explores the evolution of HIV diagnostic testing, from early antibody-based methods to advanced molecular and rapid point-of-care technologies. It highlights the impact of these innovations on early detection, treatment initiation, and global efforts to control HIV transmission.
